Cargando…

Chronic hepatitis B complicated with secondary hemochromatosis was cured clinically: A case report

Chronic hepatitis B (CHB) often causes iron overload in the liver but rarely causes severe secondary hemochromatosis (SH). A 48-year-old man was infected with CHB via vertical transmission. For 21 years, nonstandard treatment with second-line hepatitis B antiviral drugs has been administered. Repeat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Yun, Xie, Jing, Wang, Lina, He, Cong, Tan, Youwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066873/ https://www.ncbi.nlm.nih.gov/pubmed/37016704 http://dx.doi.org/10.1515/med-2023-0693

Ejemplares similares

Secondary Hemochromatosis due to Chronic Oral Iron Supplementation
por: Lands, Ronald, et al.
Publicado: (2017)

Hypoparathyroidism and Subclinical Hypothyroidism with Secondary Hemochromatosis
por: Jeong, Hyung Ki, et al.
Publicado: (2014)

Portal Hypertension Refractory Ascites Caused by Secondary Hemochromatosis
por: Tie, Jun, et al.
Publicado: (2023)

EXPERIMENTAL HEMOCHROMATOSIS
por: Rous, Peyton, et al.
Publicado: (1918)

Hereditary hemochromatosis
por: Geller, Stephen A., et al.
Publicado: (2015)

Functional cure of chronic hepatitis B – predictable?
por: Gerlich, Wolfram
Publicado: (2021)

Neonatal hemochromatosis--report of an autopsy case.
por: Suh, Y. L., et al.
Publicado: (1991)

Effect of C282Y Genotype on Self-Reported Musculoskeletal Complications in Hereditary Hemochromatosis
por: Camacho, António, et al.
Publicado: (2015)

Age as a Predictor of Significant Fibrosis Features in HBeAg-Negative Chronic Hepatitis B Virus Infection with Persistently Normal Alanine Aminotransferase
por: Tan, Youwen, et al.
Publicado: (2015)

Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis
por: Yamauchi, Ryo, et al.
Publicado: (2018)

Secondary Hemochromatosis Leading to Acute Coronary Syndrome in a Thalassemic Patient
por: Ullah, Hidayat, et al.
Publicado: (2023)

Non-HFE hemochromatosis
por: Santos, Paulo Caleb Júnior de Lima, et al.
Publicado: (2012)

Management of cardiac hemochromatosis
por: Aronow, Wilbert S.
Publicado: (2017)

Diabetes in HFE Hemochromatosis
por: Barton, James C., et al.
Publicado: (2017)

Autopsy relevance determining hemochromatosis: Case report
por: Chmieliauskas, Sigitas, et al.
Publicado: (2017)

Fatal immune-related hepatitis with intrahepatic cholestasis and pneumonia associated with camrelizumab: A case report and literature review
por: Tan, Youwen, et al.
Publicado: (2021)

Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosis
por: Seeßle, Jessica, et al.
Publicado: (2020)

Genetic diagnosis history and osteoarticular phenotype of a non-transfusion secondary hemochromatosis
por: Ruan, Dan-Dan, et al.
Publicado: (2020)

Characterization of ferroptosis in murine models of hemochromatosis
por: Wang, Hao, et al.
Publicado: (2017)

Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop
por: Block, Timothy M., et al.
Publicado: (2017)

Clinicopathological features of 11 cases of chronic hepatitis B infection complicated with primary biliary cholangitis
por: Ye, Yun, et al.
Publicado: (2023)

A “sandwich” strategy for functional cure of chronic hepatitis B
por: Wang, Xuan-Yi, et al.
Publicado: (2018)

Targeting Viral cccDNA for Cure of Chronic Hepatitis B
por: Ligat, Gaëtan, et al.
Publicado: (2020)

Functional cure for chronic hepatitis B: accessibility, durability, and prognosis
por: Song, Aixin, et al.
Publicado: (2021)

Chronic Hepatitis B Infection: New Approaches towards Cure
por: Ogunnaike, Mojisola, et al.
Publicado: (2023)

Haplotype Analysis of Hemochromatosis Gene Polymorphisms in Chronic Hepatitis C Virus Infection: A Case Control Study
por: Gerayli, Sina, et al.
Publicado: (2016)

Juvenile Hemochromatosis: A Case Report and Review of the Literature
por: Takami, Akiyoshi, et al.
Publicado: (2020)

Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B
por: Feitelson, Mark A., et al.
Publicado: (2022)

Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
por: Choi, Jonggi
Publicado: (2023)

Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis
por: Chin, Justin, et al.
Publicado: (2019)

Molecular basis of HFE-hemochromatosis
por: Vujić, Maja
Publicado: (2014)

Hereditary Hemochromatosis and Iron Metabolism
por: Carlson, Joyce, et al.
Publicado: (2001)

Polycythemia and Anemia in Hereditary Hemochromatosis
por: Khan, Adnan Aman, et al.
Publicado: (2020)

What’s Important and New in Hemochromatosis?
por: Brissot, Pierre, et al.
Publicado: (2020)

Dietary Iron Overload and Hfe(−/−) Related Hemochromatosis Alter Hepatic Mitochondrial Function
por: Fischer, Christine, et al.
Publicado: (2021)

Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
por: Kim, Sun Woong, et al.
Publicado: (2022)

A research agenda for curing chronic hepatitis B virus infection
por: Alter, Harvey, et al.
Publicado: (2018)

Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B
por: Choi, Hannah S.J., et al.
Publicado: (2021)

Hemochromatosis Gene Polymorphism as a Predictor of Sustained Virological Response to Antiviral Treatment in Egyptian Chronic Hepatitis C Patients
por: I Mehrez, Mai, et al.
Publicado: (2017)

Iron chelators reverse organ damage in type 4B hereditary hemochromatosis: Case reports
por: Wu, Ling-yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5pq7ehoimtmkv9rjsg56ta2elf